<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-046091</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Metabolic syndrome and inflammation</dc:title>
<dc:description xml:lang="en">Introduction. Patients with metabolic syndrome (MS) have an increased risk to have atherosclerosis and cardiovascular disease. Inflammation plays a crucial role in the atherosclerosis process. Some studies, even few, have shown the relationship between high levels of ferritin, with each component of the MS.   Material and methods. We studied 598 patients with overweight or obesity. We evaluated: the body composition and analytical parameters: glucose, cholesterol, triglycerides, high-density cholesterol and ferritin. Insulin resistance (IR) was defined by HOMA method. ATP III criteria were used to define MS.   Results. Higher levels of triglycerides have significant more elevated levels of ferritin (124.6 ng/ml versus 65.0 ng/ml; p = .001) or glucose (105.9 ng/ml versus 78.6 ng/ml; p = .023). The number of components of the MS increases with the values of ferritin. Patients with IR have higher values of ferritin (119.27 ng/ml versus 79.05 ng/ml; p = .001), with an area under the ROC curve of 0.678.   Conclusions. An Inflammatory parameter as ferritin could be useful and a precocious marker to evaluate chronic subclinic inflammatory process in daily medical practice (AU)</dc:description>
<dc:creator>Bellido Guerrero, Diego</dc:creator>
<dc:creator>Soto González, Alfonso</dc:creator>
<dc:creator>Vidal, Ovidio</dc:creator>
<dc:creator>Martínez del Olmo, Miguel</dc:creator>
<dc:creator>Buño Soto, Manuela</dc:creator>
<dc:creator>Pértega Díaz, Sonia</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. Los pacientes con síndrome metabólico (SM) presentan un incremento del riesgo de presentar ateroesclerosis y enfermedad cardiovascular. La inflamación desempeña un papel crucial en el proceso de la ateroesclerosis. Varios estudios, aunque son escasos, han demostrado la relación entre la elevación de los valores de ferritina, con cada uno de los componentes del SM.   Material y métodos. Se realizó un estudio de cohorte, transversal con 598 individuos con sobrepeso u obesidad. Se estudió la composición corporal y los parámetros analíticos: glucosa, insulina, colesterol total, triglicéridos, colesterol unido a lipoproteínas de alta densidad (cHDL) y ferritina. La resistencia a la insulina (RI) se valoró por el método HOMA. Para definir el SM se emplearon los criterios del ATP III.   Resultados. Se observaron valores de ferritina significativamente más altos en los pacientes con valores mayores de triglicéridos (124,6 ng/ml frente a 65,0 ng/ml; p = 0,001) o glucosa (105,9 ng/ml frente a 78,6 ng/ml; p = 0,023). El número de criterios del SM se incrementa al aumentar los valores de ferritina. Los pacientes con RI presentan valores superiores de ferritina (119,27 ng/ml frente a 79,05 ng/ml; p = 0,001), con un área bajo la curva ROC (receiver operating characteristic) de 0,678.   Conclusiones. El hecho de utilizar parámetros inflamatorios como la ferritina podría resultar útil como marcador temprano del proceso inflamatorio subclínico crónico, en la práctica clínica diaria (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);18(3): 89-95, mayo 2006. ilus, tab</dc:source>
<dc:identifier>ibc-046091</dc:identifier>
<dc:title xml:lang="es">Síndrome metabólico e inflamación</dc:title>
<dc:subject>^d22311^s22000</dc:subject>
<dc:subject>^d27937^s22045</dc:subject>
<dc:subject>^d8248</dc:subject>
<dc:subject>^d5402</dc:subject>
<dc:subject>^d28418</dc:subject>
<dc:subject>^d3963^s22066</dc:subject>
<dc:subject>^d5402^s22000</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29162</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2359^s22016</dc:subject>
<dc:subject>^d28596</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d7426^s22016</dc:subject>
<dc:subject>^d9951^s22016</dc:subject>
<dc:subject>^d1848^s22021</dc:subject>
<dc:subject>^d36032^s22012</dc:subject>
<dc:subject>^d1848^s22031</dc:subject>
<dc:subject>^d36032^s22016</dc:subject>
<dc:subject>^d6091^s22002</dc:subject>
<dc:subject>^d7500^s22002</dc:subject>
<dc:subject>^d22311^s22002</dc:subject>
<dc:subject>^d7426^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>200605</dc:date>
</metadata>
</record>
</ibecs-document>
